Reference is made to the company's stock exchange notice of 19 December 2014.

The share capital increase of NOK 9,500,000 through the issuance of 47,500,000 new shares has today been registered with the Norwegian Register of Business Enterprises, and the company share capital is now NOK 10,804,100 divided into 54,020,500 shares, each with a nominal value of NOK 0.20.

Oslo, 23 December 2014
CellCura ASA

Tore Viana-Rønningen
Chief Executive Officer
Phone: + 47 911 08 693

This information is subject of the disclosure requirements acc. to §5-12 vphl (Norwegian Securities Trading Act)

distributed by